arrow
J

John W. McEvoy

university of galway
H指数:70
被引数:5.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Residual risk in coronary artery disease: Identification of cardio–reno–metabolic and psychosocial phenotypes in a Latin American cohort of the INTERASPIRE registry

冠心病残余风险:识别INTERASPIRE注册研究拉丁美洲队列中的心-肾-代谢及心理社会表型

2026-10-150
PRE
ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey

欧洲心脏学会关于冠状动脉心脏病的预防与康复指南及当前实践:EUROASPIRE VI调查

2026-08-290
OAAI
Lipid Management and Cardiovascular Risk Assessment: Physician Perspectives from Seven Countries Across Five WHORegions — Insights from the INTERASPIRE Study

脂质管理及心血管风险评估:来自五个WHO区域七个国家医师的视角——INTERASPIRE研究启示

2026-03-230
OAAI
Optimizing lipid-lowering therapy for acute coronary syndrome using a decision support system: insights from a cluster randomized trial

利用决策支持系统优化急性冠脉综合征的降脂疗法:一项集群随机试验的见解

2025-12-010
PRE
Differential associations of cardiorenal-inflammatory markers with cardiac and cancer mortality in cancer survivors

心血管-炎症标志物与癌症幸存者心脏和癌症死亡率之间的差异性关联

2025-11-010
PRE
Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study

焦虑和抑郁与冠心病二级预防在六个WHO区域14个国家的相关性:INTERASPIRE研究

2025-11-010
OAAI
Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention

使用SCORE2与风险图表或在线计算器:对模型性能、治疗资格和心血管疾病预防的影响

2025-11-010
OAAI
Ultra-Processed Food Consumption and Subclinical Cardiac Biomarkers: A Cross-Sectional Analysis of U.S. Adults in NHANES 2001–2004

超加工食品消费与亚临床心脏生物标志物:对美国成年人NHANES 2001–2004数据的横断面分析

2025-10-200
OAAI
Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients

动脉粥样硬化性心血管疾病患者复发性事件预测中SMART2模型之外的心理因素

2025-09-010
OAAI
Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease: results from the combined EUROASPIRE IV and V studies

慢性肾脏病在冠心病患者中的患病率及预后重要性:来自EUROASPIRE IV和V联合研究的结果

2025-09-011
PRE
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE

心血管疾病患者Lp(a)检测与管理的医师观点:INTERASPIRE项目五个世界卫生组织区域七个国家的访谈

2025-08-011
PRE